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We investigated 21149 G/T SNP in 156 patients with SLE and 173 patients with RA, and in 123 healthy individuals (control group). Patients with SLE consisted of 134 (85.9%) women and 22 (14.1%) men, with a mean age of 43.4 years. SLE diagnosis was determined using the American College of Rheumatology classification criteria. 9 Patients with RA consisted of: 132 (76.3%) women and 41 (23.7%) men, with a mean age of 57.4 years; all fulfilled the RA diagnostic criteria. 10 The control group consisted of 40 (32.5%) women and 83 (67.5%) men, with a mean age of 38.7 years. The study was approved by the ethics committee of The Third Medical Faculty, Charles University, Prague, Czech Republic.
The PCR-RFLP (restriction fragment length polymorphism) method was used for 21149 G/T SNP detection. During PCR, the 137 base pairs (bp) region of the PRL extrapituitary promoter was amplified by using the following primers: forward 59-GCAGGTCA AGATAACCTGGA and reverse 59-CATCTCAGAGTTGAATTTATT TCCTT. For RFLP, ApoI restriction endonucleasis was used. The genotypes identified were TT homozygote characterised by 120 and 17 bp, GG homozygote characterised by 85, 35 and 17 bp, and GT heterozygote characterised by 120, 85 and 35 bp + 17 bp DNA 
There was no difference in genotype and allele frequencies in the SLE group compared with healthy Czech individuals (table 1) . Our results support previous Italian findings, 8 but differ from the UK report. 7 However, with respect to the specific organ manifestation of SLE (table 1) , we detected an association between the G allele and articular involvement (Pc = 0.0086, OR 2.56, 95% CI 1.51 to 4.33). Based on age when SLE was diagnosed, we observed a GG genotype frequency of 44.8% in the 21-40 years subgroup compared with 15.8% and 24.0% in the ,20 years and .40 years subgroup, respectively (Pc = 0.023, OR 2.94, 95% CI 1.43 to 5.96). Additionally, we correlated the presence of alleles and genotypes of 21149 G/T SNP with antibodies against antinuclear antibody, double-stranded DNA, Sm, RNP, Ro and La, but no connection was found (data not shown).
Significantly higher heterozygote GT genotype was detected in the RA group compared with the controls (Pc = 0.039, OR 1.82, 95% CI 1.14 to 2.94). We observed no differences in homozygote genotypes or in allele frequencies between patients with RA and controls (table 1). Across the groups, no gender differences in genotype distribution or allele frequencies were identified (data not shown).
In conclusion, the presence of the G allele and GG genotype of the PRL extrapituitary promoter 21149 G/T SNP is associated with certain clinical features of SLE. The GT genotype is a predisposing genetic factor for RA. Further investigation on this is required. Subsequently, the flow signals in the joints were divided into a superficial pattern and a deep pattern on the basis of their dominant location in the pannus on both longitudinal and transverse scans. Following this, we compared 61 joints with superficial pattern signals and 36 joints with deep pattern signals with respect to the intensities of the colour flow signals (graded 0-3 by the modified Klauser's method), 9 synovial effusion
